Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Latest filing published 03 Oct 2022 for Biohaven Pharmaceutical Holding Co Ltd., €1.7M.
Insider track record
Disclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Elyse Stock: trading record in brief
Elyse Stock is a declared insider of Biohaven Pharmaceutical Holding Co Ltd. (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 15 October 2019 to 3 October 2022, the count stands at 36 filings.
The open-market record consists of 9 sales worth €5.6M, with no purchase. The rest of the record consists of 6 share grants and 19 option exercises.
The newest entry dates from 3 October 2022: a transaction of €812k, in Biohaven Pharmaceutical Holding Co Ltd. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Elyse Stock
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
11,090 shares@ US$148.5093.1% of flowCommon SharesSEC:0001562180-22-006951:0
937 shares0Common SharesSEC:0001562180-22-000439:0
3,750 shares0Common SharesSEC:0001562180-22-000352:0
3,362 shares@ US$20.793.6% of flowCommon SharesSEC:0001562180-21-007738:0
3,375 shares0Common SharesSEC:0001562180-21-007303:0
5 of 5 declarations
